The association between follicle stimulating hormone and glutathione peroxidase activity is dependent on abdominal obesity in postmenopausal women
- 242 Downloads
Menopause is frequently associated with an increase in visceral fat, thus modifying redox status by promoting oxidative damage and decreasing antioxidant defense systems. It is known that at higher concentrations estradiol has some antioxidant properties, while its decline in postmenopause is associated with pro-oxidant effects. However, the role of follicle stimulating hormone (FSH) in antioxidant defense in postmenopausal women is still not well elucidated. Therefore, we aimed to evaluate the potential complex association between visceral obesity, FSH and enzymatic antioxidant defense as measured by glutathione peroxidase (GPx) in postmenopausal women.
A total of 150 postmenopausal women (mean age 56.6 ± 4.8 years), among them 50 normal weight and 100 overweight/obese, were included. GPx activity, FSH, luteinizing hormone, estradiol, total testosterone, cardiometabolic and anthropometric parameters, were determined.
With increasing tertiles of serum FSH levels, significant increase in GPx activity (P = 0.005) was found. Also, the highest number of overweight/obese subjects were in the group with the lowest FSH values (χ 2 = 14.9, P < 0.001). After multiple linear regression analysis, the relationship between GPx and FSH disappeared, whereas only higher waist circumference (β = −0.218, P = 0.045) predicted lower FSH level (adjusted R 2 = 0.227).
Higher GPx activity is associated with higher FSH level, but abdominal obesity may be the underlying determinant of this relationship.
KeywordsAntioxidant defense Follicle stimulating hormone Obesity Postmenopausal women
This work was financially supported in part by a grant from the Ministry of Education, Science and Technological Development, Republic of Serbia (Project No. OI 175035-J. Kotur-Stevuljevic).
Compliance with ethical standards
Conflict of interest
The authors declared no conflicts of interest.
The study protocol was approved by the Ethical Committee of Primary Health Care Center in Podgorica, Montenegro and the research was carried out in compliance with the Declaration of Helsinki.
All the participants provided written informed consent.
- 4.Randolph JF Jr, Zheng H, Sowers MR, Crandall C, Crawford S, Gold EB et al (2011) Change in follicle-stimulating hormone and estradiol across the menopausal transition: effect of age at the final menstrual period. J Clin Endocrinol Metab 96:746–754. doi: 10.1210/jc.2010-1746 CrossRefPubMedGoogle Scholar
- 9.Lubrano C, Valacchi G, Specchia P, Gnessi L, Rubanenko EP, Shuginina EA et al (2015) Integrated haematological profiles of redox status, lipid, and inflammatory protein biomarkers in benign obesity and unhealthy obesity with metabolic syndrome. Oxid Med Cell Longev 2015:490613. doi: 10.1155/2015/490613 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Borekci B, Ingec M, Kumtepe Y, Karaca M, Koc F, Salman S et al (2009) Effect of estrogen, progesterone, LH and FSH on oxidant and antioxidant parameters in rat uterine tissue. Int J Fertil Steril 3:119–128Google Scholar
- 21.Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644 CrossRefPubMedGoogle Scholar
- 29.Gutierrez-Lopez L, Garcia-Sanchez JR, MdeJ Rincon-Viquez, Lara-Padilla E, Sierra-Vargas MP, Olivares-Corichi IM (2012) Hypocaloric diet and regular moderate aerobic exercise is an effective strategy to reduce anthropometric parameters and oxidative stress in obese patients. Obes Facts 5:12–22. doi: 10.1159/000336526 CrossRefPubMedGoogle Scholar
- 31.Stefanović A, Kotur-Stevuljević J, Spasić S, Bogavac-Stanojević N, Bujisić N (2008) The influence of obesity on the oxidative stress status and the concentration of leptin in type 2 diabetes mellitus patients. Diabetes Res Clin Pract 79:156–163. doi: 10.1016/j.diabres.2007.07.019 CrossRefPubMedGoogle Scholar
- 33.Massafra C, Buonocore G, Gioia D, Sargentini I, Farina G (1997) Effects of estradiol and medroxyprogesterone acetate treatment on erythrocyte antioxidant enzyme activities and malondialdehyde plasma levels in amenorrhoeic women. J Clin Endocrinol Metab 82:173–175. doi: 10.1210/jcem.82.1.3688#sthash.fHO1phI3.dpuf CrossRefPubMedGoogle Scholar
- 34.Bednarek-Tupikowska G, Bohdanowicz-Pawlak A, Bidzinska B, Milewicz A, Antonowicz-Juchniewicz J, Andrzejak R (2001) Serum lipid peroxide levels and erythrocyte glutathione peroxidase and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol 15:298–303. doi: 10.1080/gye.15.4.298.303 CrossRefPubMedGoogle Scholar
- 35.Massafra C, Gioia D, De Felice C, Picciolini E, De Leo V, Bonifazi M et al (2000) Effects of estrogens and androgens on erythrocyte antioxidant superoxide dismutase, catalase and glutathione peroxidase activities during the menstrual cycle. J Endocrinol 167:447–452. doi: 10.1677/joe.0.1670447 CrossRefGoogle Scholar